Roka Closes $20 Mln Series C Round
Roka Bioscience has closed a $20 million Series C round of funding. OrbiMed Advisors, New Enterprise Associates, Inc., TPG Biotech and Gen-Probe Incorporated participated, according to a statement. Warren, N.J.-based Roka develops solutions using molecular technologies for the industrial markets.
28 July 2011•2 mins read
